Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion

Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion

PurposeTo compare the efficacy and the injection number of intravitreal ranibizumab (IVR) monotherapy vs. intravitreal ranibizumab plus dexamethasone (IVR + DEX) implants for macular edema (ME) secondary to retinal vein occlusion (RVO).MethodsThis prospective, control trial comprised 96 eyes of 96 p...

Full description

Bibliographic Details
Main Authors: Xuemei Liang, Baiyun Shen, Zuguo Ou, Hongmei An, Li Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Medicine
Subjects:
retinal vein occlusion
macular edema
ranibizumab
dexamethasone implant
efficacy and safety
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.930508/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.930508/full

Similar Items